Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats.
Role of the nucleolus in neurodegenerative disease with particular reference to the retina: a review.
Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Brace: A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies.
Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.
Retinal layer segmentation of macular OCT images using boundary classification.
Multiple sclerosis: Creating a STIR-MRI sequence improves detection of spinal cord lesions.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Interleukin-17 in human inflammatory diseases.
Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet.
Neurology issues in schizophrenia.
Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
Multiple sclerosis: Evidence for B-cell exchange across the blood-brain barrier.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Identifying physical activity information needs and preferred methods of delivery of people with multiple sclerosis.
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
Pages
« first
‹ previous
…
485
486
487
488
489
490
491
492
493
…
next ›
last »